Diary - News
All news Data Advancing the Clinical Utility of ImmunID’s ImmunTraCkeR®
ImmunID today announced the publication of a short report in the Journal for ImmunoTherapy of Cancer (JITC) showing that the analysis of peripheral T cell receptor diversity using the company’s ImmunTraCkeR® assay is associated with clinical outcomes following Ipilimumab treatment in metastatic melanoma.
